Actively Recruiting

Age: 18Years +
All Genders
NCT07178886

Breast Reconstruction and Radiotherapy

Led by Janine M. Simons MD PhD · Updated on 2025-09-17

750

Participants Needed

1

Research Sites

384 weeks

Total Duration

On this page

Sponsors

J

Janine M. Simons MD PhD

Lead Sponsor

Z

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborating Sponsor

AI-Summary

What this Trial Is About

If the whole breast is removed because of breast cancer, several options for breast reconstruction are available. All these options have an increased complication risk if a patient has been or will be treated with radiotherapy. However, only a few high-quality studies addressed patient satisfaction and complication risks, both in terms of timing (prior to or after irradiation) and type of reconstruction (implant or own tissue). As radiotherapy indications expand and more patients desire a reconstruction, this is a progressively relevant issue. Through this nationwide prospective study, the investigators aim to identify the most ideal treatment strategy by comparing different reconstruction options in terms of patient reported outcomes (PROs), toxicity, oncological safety and costs. These results will enable improvement of shared decision-making and cost-effectiveness of breast reconstruction strategies in case of radiotherapy.

CONDITIONS

Official Title

Breast Reconstruction and Radiotherapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Diagnosed with unilateral non-metastatic breast cancer
  • Undergoing or scheduled for mastectomy and adjuvant radiotherapy
  • Willing and able to provide written informed consent
Not Eligible

You will not qualify if you...

  • History of ductal carcinoma in situ (DCIS) or invasive breast cancer
  • Previous thoracic radiotherapy treatment
  • History of other malignancies except basal or squamous cell skin cancer, in situ carcinoma of the cervix, or other malignancies disease-free for at least 5 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Erasmus Medical Center

Rotterdam, Netherlands

Actively Recruiting

Loading map...

Research Team

J

Janine M Simons, MD PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here